|Articles|May 16, 2016

Brazilian Monkeys Test Positive for Zika

Author(s)Sarah Anwar

Seven monkeys in Ceará, Brazil have tested positive for the Zika virus.

Seven monkeys in Ceará, Brazil have tested positive for the Zika virus.

In a recent preprint article published online in bioRxiv, the authors tested sera and oral swab samples from 15 marmoset and 9 capuchin monkeys in the Brazilian state where Zika virus is epidemic and is linked to several cases of microcephaly. Four samples from the marmoset group and three samples from the capuchin group tested positive for the virus.

The authors noted that this is the first reported detection of the virus in neotropical (New World) primates, which suggests that they can act as a reservoir.

Amplified PCR assays revealed that the virus was a 100% match to the human Zika strain circulating in Latin America.

The monkeys sampled in the study inhabited different regions of the state. All sampled marmosets were free-range, while 8 of the 9 capuchins were pets. The authors stated that, at the time of the article's submission, Ceará had reported 363 cases of microcephaly since October 2015, of which 70 cases tested positive for the Zika virus. The authors noted, “Crucially, cases of microcephaly occurred in municipalities from where viremic monkeys were sampled.”

Since Zika is asymptomatic in approximately 80% of infected individuals, it is difficult to estimate prevalence; however, in early May 2016, Brazil confirmed that 1,217 microcephaly cases nationwide were linked to Zika infection.

The Centers for Disease Control and Prevention (CDC) confirms that there have been no reports of Zika virus transmission through contact with an infected animal. Furthermore, the CDC was not notified of any cases of animal illness due to the Zika virus; nonetheless, research is lacking in that area.

For more information on Zika virus infection in animals, please visit American Veterinarian™: http://www.americanveterinarian.com/news/brazilian-monkeys-test-positive-for-zika.


Related to this article

CDC Responds to Surge in Rabies Exposures
A "Clinician Outreach" from the Centers for Disease Control and Prevention (CDC) in April anticipated an increase in rabies exposures, and the striking surge in case reports this summer prompted a recent health advisory alert from the federal agency.
This Week's Top 5 Infectious Disease News Stories: September 12-September 18, 2026
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
Measles Update: September 18, 2026
The latest CDC numbers show a 5.37% increase of measles cases from week-to-week. In Pennsylvania, the fourth measles-related death was reported in 2026. Additionally, the CDC has made a change in the way it will report deaths.
New Diagnositics for Legionella Pneumonia May Streamline Care Continuum
Reported cases of Legionnaires’ disease have been on the rise for the past decade, and identifying Legionella bacteria requires specialized testing in the microbiology lab. Here is a clinical overview of Legionella bacteria, including required testing, treatment, and reporting to public health officials.
Ceftriaxone Safety: Separating Signal From Risk
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.